5-Aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 26, Issue 2, 2007, Pages 75-82

  Alvarez, Maria Gabriela ^a   Lacelli, M S ^a   Rivarola, Viviana ^a   Batlle, Alcira ^b   Fukuda, Haydee ^b,c  

^a DEPARTAMENTO DE QUÍMICA   (Argentina)

^b CIPYP CONICET   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

5 aminolevulinic acid; Apoptosis; Necrosis; Photodynamic therapy; Photosensitisation

Indexed keywords

AMINOLEVULINIC ACID; DEFEROXAMINE; IRON CHELATING AGENT; PROTOPORPHYRIN;

ANALYTIC METHOD; APOPTOSIS; CANCER CELL; CELL DEATH; CELL STRUCTURE; CHROMATIN; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INCUBATION TIME; LYSOSOME; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION DOSE;

EID: 34548071136     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v26.i2.20     Document Type: Conference Paper

References (25)

1. Sassa S. Regulation of the genes for heme pathway enzymes in erythroid and in non erythroid cells. Int J Cell Cloning. 1990;8:10-26.
2. Batlle AM del C. Porphyrins, Porphyrias, cancer and photodynamic therapy - a model for carcinogenesis. J Photochem Photobiol B: Biol. 1993;20:5-22.
3. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 1997;5:235-51.
4. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer. 1997;79:2282-308.
5. Oleinick NL, Morris RL and Belichenko I. Apoptosis in response to photodynamic therapy: what, where, why and how. Photochem Photobiol Sci. 2002;1:1-22
6. Luo Y, Kessel D. Initiation of apoptosis versus necrosis by photodynamic therapy with chloro-aluminum phtalocyanine. Photochem Photobiol. 1997;66:479-83
7. Merlin JL, Azzi S, Lignon D, Ramacci C, Zeghari N, Guillemin F. MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy. Eur J Cancer. 1992;28:1452-8.
8. Alvarez MG, La Penna M, Yslas EI, Rivarola V, Durantini EN. Photodamaging effects of porphyrin in a human carcinoma cell line. Chem. Educator. 2000;5:24-6.
9. Schoenfeld N, Mamet R, Nordenberg Y, Shafran M, Babushkin T, Malik Z. Protoporphyrin biosynthesis in melanoma B 16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int J Cancer. 1994;56:106-12.
10. Navone NM, Polo C, Frisardi A, Batlle AM del C. Mouse mammary carcinoma PBGase and hydroxymethylbilane synthetase. Comp Biochem Physiol B. 1991;98:67-71.
11. Dailey HA, Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem J. 1983;223:441-5.
12. Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann NY Acad Sci. 1964;19:758-68.
13. Hanania H, Malik Z. The effect of EDTA and serum on endogenous porphyrins accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett. 1992;65:127-31.
14. Ortell B, Tanew A, Honigsmann H. Lethal photosensitization by endogenous porphyrins of PAM cells-modification by desferrioxamine. J Photochem Photobiol B: Biol. 1993;17:273-8
15. Berg K, Anholt H, Bech O, Moan J. The influence of iron chelators on the accumulation of Protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Br J Cancer. 1996;74:688-97.
16. Liu H, Xu S, Zhang Ch. Influence of CaNa2EDTA on topical 5-aminolevulinic acid photodynamic therapy. Chin Med J. 2004;117:922-6.
17. Fabris C, Valduga G, Miotto G, Borsetto L, Jori G, Garbisa S, Reddi E. Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. Cancer Res. 2001;61:7495-500.
18. Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B: Biol. 1998;42:89-95.
19. Kessel D, Luo Y. Intracellular sites of photodamage as a factor in apoptotic cell death. J Porphyrins Phtalocyanines. 2001;5:181-4.
20. Kessel D, Luo Y. Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ. 1999;6:28-35.
21. Oleinick NL, Antunez AR, Clay ME, Rihter BD, Kenney ME. New phtalocyanine photosensitizers for photodynamic therapy. Photochem Photobiol. 1993;57:242-7.
22. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Apoptosis and necrosis induced with light and 5-aminolevulinic acid derived protoporphyrin IX. Br J Cancer. 1993;74:22-9.
23. Villanueva A, Durantini EN, Stockert JC, Rello S, Vidania R, Cañete M, Juarranz A, Arranz R, Rivarola V. Photokilling of cultured tumor cells by the porphyrin derivative CF3. Anti-Cancer Drug Des. 2001;16:279-90.
24. Milanesio ME, Álvarez MG, Silber JJ, Rivarola V, Durantini EN. Photodynamic activity of monocationic and non-charged methoxyphenylporphyrin derivatives in homogeneous and biological media. Photochem Photobiol Sci. 2003;2:926-33.
25. Alvarez MG, Principe F, Milanesio ME, Durantini EN, Rivarola V. Photodynamic damages induced by a monocationic porphyrin derivative in a human carcinoma cell line. Int J Biochem Cell Biol. 2005 37:2504-12.